MX2019000086A - Formas cristalinas de un compuesto de tetraciclina sustituido con 9-aminometilo y un metodo para la preparacion de las mismas. - Google Patents
Formas cristalinas de un compuesto de tetraciclina sustituido con 9-aminometilo y un metodo para la preparacion de las mismas.Info
- Publication number
- MX2019000086A MX2019000086A MX2019000086A MX2019000086A MX2019000086A MX 2019000086 A MX2019000086 A MX 2019000086A MX 2019000086 A MX2019000086 A MX 2019000086A MX 2019000086 A MX2019000086 A MX 2019000086A MX 2019000086 A MX2019000086 A MX 2019000086A
- Authority
- MX
- Mexico
- Prior art keywords
- crystal form
- preparation
- method therefor
- tetracycline compounds
- substituted tetracycline
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/65—Tetracyclines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/54—Spiro-condensed
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Indole Compounds (AREA)
Abstract
La presente invencion pertenece al campo de la tecnologia farmaceutica, y a las formas cristalinas de un compuesto de tetraciclina sustituido con 9-aminometilo y a un procedimiento para la preparacion del mismo; mas especificamente, la presente invencion se refiere a formas cristalinas del compuesto representado por la formula (1), a un procedimiento para la preparacion de formas cristalinas del compuesto representado por la formula (1) y al uso de dichas formas cristalinas en la fabricacion de un medicamento para el tratamiento y/o prevencion de una enfermedad infecciosa provocada por bacterias sensibles a tetraciclina y/o bacterias resistentes a tetraciclina. [Ver fórmula (1)].
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610457261 | 2016-06-22 | ||
PCT/CN2017/089470 WO2017219994A1 (zh) | 2016-06-22 | 2017-06-22 | 9-氨基甲基取代的四环素类化合物的晶型及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2019000086A true MX2019000086A (es) | 2019-05-02 |
Family
ID=60783195
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2019000086A MX2019000086A (es) | 2016-06-22 | 2017-06-22 | Formas cristalinas de un compuesto de tetraciclina sustituido con 9-aminometilo y un metodo para la preparacion de las mismas. |
Country Status (22)
Country | Link |
---|---|
US (1) | US10633337B2 (es) |
EP (1) | EP3476831B8 (es) |
JP (1) | JP6883593B2 (es) |
KR (1) | KR102205843B1 (es) |
CN (1) | CN109563035B (es) |
AU (1) | AU2017282891B2 (es) |
BR (1) | BR112018076726A2 (es) |
CA (1) | CA3028014C (es) |
CL (1) | CL2018003739A1 (es) |
CO (1) | CO2019000513A2 (es) |
ES (1) | ES2906885T3 (es) |
IL (1) | IL263868B (es) |
MA (1) | MA45461A (es) |
MX (1) | MX2019000086A (es) |
MY (1) | MY186900A (es) |
PE (1) | PE20190810A1 (es) |
PH (1) | PH12018502680A1 (es) |
RU (2) | RU2764723C2 (es) |
SG (1) | SG11201811499WA (es) |
TW (1) | TWI656116B (es) |
WO (1) | WO2017219994A1 (es) |
ZA (1) | ZA201900274B (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USD962414S1 (en) | 2020-02-28 | 2022-08-30 | Beijing Xiaomi Mobile Software Co., Ltd | Fan |
CA3179596A1 (en) * | 2020-06-11 | 2021-12-16 | Tadeusz Warchol | Crystalline forms of omadacycline, methods of synthesis thereof and methods of use thereof |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004064728A2 (en) * | 2003-01-16 | 2004-08-05 | Paratek Pharmaceuticals, Inc. | Use of specific tetracycline compounds in therapy |
AR057649A1 (es) * | 2005-05-27 | 2007-12-12 | Wyeth Corp | Formas solidas cristalinas de tigeciclina y metodos para preparar las mismas |
US8252946B2 (en) * | 2007-11-14 | 2012-08-28 | Sandoz Ag | Crystalline forms of tigecycline hydrochloride |
EP2252579A2 (en) * | 2008-01-23 | 2010-11-24 | Sandoz AG | Antibiotic compounds |
TWI680117B (zh) * | 2008-05-23 | 2019-12-21 | 派洛泰克藥物股份有限公司 | 四環素化合物之甲苯磺酸鹽及同素異形體 |
CA2842838C (en) * | 2011-07-26 | 2017-04-25 | Kbp Biosciences Co., Ltd. | 9-aminomethyl substituted tetracycline compounds |
CN102417465B (zh) * | 2011-10-27 | 2014-03-12 | 宫宁瑞 | 替加环素新晶型及其制备方法 |
-
2017
- 2017-06-22 CN CN201780026902.4A patent/CN109563035B/zh active Active
- 2017-06-22 SG SG11201811499WA patent/SG11201811499WA/en unknown
- 2017-06-22 AU AU2017282891A patent/AU2017282891B2/en active Active
- 2017-06-22 TW TW106120947A patent/TWI656116B/zh active
- 2017-06-22 US US16/312,404 patent/US10633337B2/en active Active
- 2017-06-22 WO PCT/CN2017/089470 patent/WO2017219994A1/zh unknown
- 2017-06-22 MX MX2019000086A patent/MX2019000086A/es unknown
- 2017-06-22 EP EP17814732.8A patent/EP3476831B8/en active Active
- 2017-06-22 PE PE2018003293A patent/PE20190810A1/es unknown
- 2017-06-22 CA CA3028014A patent/CA3028014C/en active Active
- 2017-06-22 MY MYPI2018002825A patent/MY186900A/en unknown
- 2017-06-22 IL IL263868A patent/IL263868B/en unknown
- 2017-06-22 ES ES17814732T patent/ES2906885T3/es active Active
- 2017-06-22 RU RU2019101248A patent/RU2764723C2/ru active
- 2017-06-22 RU RU2022100160A patent/RU2022100160A/ru unknown
- 2017-06-22 BR BR112018076726-3A patent/BR112018076726A2/pt active Search and Examination
- 2017-06-22 KR KR1020187037477A patent/KR102205843B1/ko active IP Right Grant
- 2017-06-22 JP JP2018567683A patent/JP6883593B2/ja active Active
- 2017-06-22 MA MA045461A patent/MA45461A/fr unknown
-
2018
- 2018-12-18 PH PH12018502680A patent/PH12018502680A1/en unknown
- 2018-12-21 CL CL2018003739A patent/CL2018003739A1/es unknown
-
2019
- 2019-01-15 ZA ZA2019/00274A patent/ZA201900274B/en unknown
- 2019-01-18 CO CONC2019/0000513A patent/CO2019000513A2/es unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12016502382A1 (en) | Substituted indazole compounds as irak4 inhibitors | |
GEP20207160B (en) | New piperidinyl derivatives, a process for their preparation and pharmaceutical compositions containing them | |
MX2018000396A (es) | Compuestos aza sustituidos como inhibidores de cinasa 4 asociada al receptor de interleucina 1 (irak-4). | |
MX2022009300A (es) | Derivado de quinolina muy puro y metodo para su produccion. | |
MY188447A (en) | Indazole compounds as fger kinase inhibitor, preparation and use thereof | |
PH12015501881B1 (en) | Amide compounds for the treatment of hiv | |
PH12018500061A1 (en) | Oxysterols and methods of use thereof | |
MX2020001757A (es) | Compuestos, sales de los mismos y metodos para el tratamiento de enfermedades. | |
EA033084B1 (ru) | Бигетероарильные соединения и их применения | |
DOP2019000193A (es) | Nuevo compuesto heterocíclico, su método de preparación y composición farmacéutica que lo comprende | |
PH12017500533A1 (en) | 1-alkyl-6-oxo-1, 6-dihydropyridin-3-yl compounds and use as sgrm modulators | |
EA201991253A1 (ru) | Бензодиазолиевые соединения в качестве ингибиторов enac | |
BR112017005242A2 (pt) | composto, composição farmacêutica, e, composto para uso. | |
MX2016009589A (es) | Enonas piridazolilo y pirimidinilo triciclicas sustituidas con arilo y arilalquilo como moduladores de la inflamacion antioxidantes. | |
MX2016001855A (es) | Nuevos aza-oxo-indoles para el tratamiento y profilaxis de la infeccion por virus sincitial respiratorio. | |
MX2021012096A (es) | Compuestos de indenilo, composiciones farmaceuticas y usos medicos del mismo. | |
MX2016002718A (es) | Derivados de ceto-imidazopiridina como moduladores del receptor huerfano relacionado con receptor retinoide (porc). | |
MX2022006229A (es) | Composiciones y metodos para el tratamiento de resistencia a la insulina. | |
MX2018016339A (es) | Compuestos heterociclicos antiinfecciosos y sus usos. | |
PH12016502568A1 (en) | Novel heterocyclic compound | |
PH12018502680A1 (en) | Crystal forms of 9-aminomethyl substituted tetracycline compound and preparation method thereof | |
MX2018002177A (es) | Nuevo derivado de catecol y composicion farmaceutica que comprende el mismo. | |
SG11201803867TA (en) | Sodium channel blocker | |
MX2015010790A (es) | Derivados de anilina sustituidos con n-heteroarilo como antivirales de vhc. | |
PH12017501560A1 (en) | Tetrahydropyranyl benzamide derivatives |